This page is dedicated to the Bladder Exstrophy-Epispadias Complex (BEEC) research study, one of 57 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
The Bladder Exstrophy-Epispadias Complex research study, established at Boston Children’s in 2023 [previous study history], is led by Drs. Ted Lee, Nina Mann, Richard Lee, and Joseph Borer, and has enrolled 112 patients and their families. The study aims to identify genetic causes of BEEC and provide personalized medicine.